Ashish Upadhyay, MD

Associate Professor, Medicine

Ashish Upadhyay
Renal Section, Evans Biomedical Research Building – 650 Albany Street, Suite 5A

Biography

Dr. Upadhyay is a board-certified nephrologist with academic interests in examining the mechanisms of cardiovascular disease in patients with chronic kidney disease (CKD), hemodialysis systems, and evidence-based medicine (EBM). He has conducted epidemiologic research in the Framingham Heart Study, led the evidence review team for the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on lipid management in CKD, and participated in the evidence review teams for the KDIGO clinical practice guidelines on blood pressure management in CKD and anemia management in CKD. He maintains an active clinical practice in general nephrology, hemodialysis, and peritoneal dialysis, and is the Program Director of BU’s Nephrology Fellowship Training Program. In addition, he directs research and EBM curriculum of BU’s Internal Medicine Residency Program, and was an Associate Program Director of the Internal Medicine Residency Program from 2012 to 2018. Outside of BU, Dr. Upadhyay serves as a voting member of the Association for the Advancement of Medical Instrumentation (AAMI)’s Renal Disease and Detoxification Committee, the primary source of national and international consensus standards for hemodialysis technology and dialysis water sterilization processes.

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
  • Program Director, Nephrology Fellowship Program, Boston University School of Medicine
  • Director, Scholarship and EBM, Internal Medicine Residency Program, Boston University School of Medicine

Education

  • Tribhuvan University, MBBS

Publications

  • Published on 6/4/2021

    Kamel MH, Mahmoud H, Zhen A, Liu J, Bielick CG, Mostaghim A, Lin N, Chitalia V, Ilori T, Waikar SS, Upadhyay A. End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts. PLoS One. 2021; 16(6):e0252679. PMID: 34086775.

    Read at: PubMed
  • Published on 5/1/2021

    Kumari A, Ranjan P, Chopra S, Kaur D, Kaur T, Upadhyay AD, Isaac JA, Kasiraj R, Prakash B, Kumar P, Dwivedi SN, Vikram NK. Knowledge, barriers and facilitators regarding COVID-19 vaccine and vaccination programme among the general population: A cross-sectional survey from one thousand two hundred and forty-nine participants. Diabetes Metab Syndr. 2021 May-Jun; 15(3):987-992. PMID: 33984818.

    Read at: PubMed
  • Published on 9/23/2020

    Bonner R, Albajrami O, Hudspeth J, Upadhyay A. Diabetic Kidney Disease. Prim Care. 2020 Dec; 47(4):645-659. PMID: 33121634.

    Read at: PubMed
  • Published on 4/21/2020

    Verma A, Patel AB, Upadhyay A, Waikar SS. CREDENCE: Significant Victory for Diabetic Kidney Disease. Trends Endocrinol Metab. 2020 06; 31(6):391-393. PMID: 32327275.

    Read at: PubMed
  • Published on 4/7/2020

    Neupane G, Acharya S, Bhattarai M, Upadhyay A, Belbase B, Bhandari M, Pandeya D, Pokharel S, Ghimire S, Thapa G, Karmacharya B, Bhatt MR, Spertus JA, Neupane D, Timsina L, Pokharel Y. Study, Design, and Rationale of Noncommunicable Diseases in Nepal (NCD Nepal) Study: A Community-Based Prospective Epidemiological and Implementation Study in Rural Nepal. Glob Adv Health Med. 2020; 9:2164956120917379. PMID: 32284911.

    Read at: PubMed
  • Published on 11/26/2019

    Dennis M, Batalini F, Demers L, Upadhyay A. Overcoming barriers to resident scholarly productivity and research at a large academic institution. MedEdPublish. 2019; 8(3):1-11.

    Read at: Custom
  • Published on 9/2/2019

    Upadhyay A. Dialyzer reuse: is it safe and worth it? J Bras Nefrol. 2019 Sep 02; 41(3):312-314. PMID: 31508668.

    Read at: PubMed
  • Published on 3/8/2018

    Toth PP, Dwyer JP, Cannon CP, Colhoun HM, Rader DJ, Upadhyay A, Louie MJ, Koren A, Letierce A, Mandel J, Banach M. Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease. Kidney Int. 2018 06; 93(6):1397-1408. PMID: 29526502.

    Read at: PubMed
  • Published on 6/13/2017

    Upadhyay A, Susantitaphong P, Jaber BL. Ultrapure versus standard dialysate: A cost-benefit analysis. Semin Dial. 2017 09; 30(5):398-402. PMID: 28608933.

    Read at: PubMed
  • Published on 3/1/2017

    Chen C, Upadhyay A. Renal denervation for uncontrolled hypertension: critical review of the evidence. Curr Opin Nephrol Hypertens. 2017 Mar; 26(2):114-122. PMID: 27922849.

    Read at: PubMed

View 31 more publications: View full profile at BUMC

View all profiles